JOBS LOST IN FIRM'S U.S. MOVE

DAVID ELKS

12:00 - 02 July 2003

A Medical research company has shut down its South Cheshire headquarters, despite winning 900,000 of orders for technology to help fight the deadly Sars virus. An undisclosed number of staff at Crewe-based Osmetech have been made redundant after the company transferred its research operations to America.

The news comes as the company reported a boom in sales of a blood gas analyser to China over the past month to monitor patients with Severe Acute Respiratory Syndrome (Sars).
A spokesman for Osmetech, which employs 38 staff at the town's business park, said the decision followed a 2.2 million deal to take over pharmaceutical giant Roche's sensor division OPTI in March.
He said: "When they bought the company they also took on about 50 new staff involved in research and marketing.
"It was felt that Osmetech is still a fairly small company and having research operations split between the two sites was not efficient."

Following the move, the majority of research will now be conducted at OPTI's headquarters in Atlanta, while the company's registered headquarters has shifted to London.
This will enable the company to continue its listing on the London Stock Exchange's Alternative Investment Market. The executive directors will also be based in London.
The spokesman said that a number of workers in the North-West of England will remained involved in research while working from home.

The news comes as the company confirmed it had picked up 910,000 of orders for its equipment following the Sars virus outbreak in the Far East.
The handheld device cannot diagnose the virus, although it has optical sensors which can measure vital bodily conditions during treatment of its pneumonia-like symptoms. It measures blood gas, electrolyte and metabolite levels and can be used for measuring the oxygen saturation and acid-base balance in Sars patients.
Osmetech said this would be particularly useful in cases where treatment required the use of a ventilator for "supplemental oxygen" therapy.

The deal will help Osmetech, which is estimated by analysts Evolution Beeson Gregory to suffer losses of 3.2 million in the current financial year, push its way towards profitability. The orders received this month are already 10 times higher than the last financial year.

In January the company confirmed it had won approval from the U.S. Food and Drug Administration for its sensor, which uses electronics technology to 'sniff' out bacteria which can cause miscarriages - a market worth between 900 million and 1.2 billion in the U.S.

The group cut losses by 20 per cent to 533,000 in the six months to January and is due to report its annual figures on July 30.

david.elks@thesentinel.co.uk

from another board ... quote


"Just spoken to David Sandilands he confirms USA rumours ... to cut a long story short this will SPEED UP product development, CUT OVERHEADS AND COSTS further and is seen by the company as an excellent move forward. He sounded extremely happy and full of it, positively brimming at the success of the OPTI device so far (and hinting that it is being very sucessfully sold for Non sars countries as well) and I got the distinct impression we are going to hear a lot of bullish things in the results at the end of the month. He also said that now money is being generated, the risk profile of the company has fallen considerably and they intend on having a big drive in attracting Institutional investors both in the UK and the USA - noting that the company are indeed frustrated by the lack of share price movement".

Link to Michael Walters site, open to non subscribers following the theft of his server in New York. Good write up on OMH


http://www.michaelwalters.com/comments.phtml


Please note that this was written without taking into account the Crewe closure and the move to the U.S.A.

go to


http://osmetech.netforce.net/opti/index.html


to see a presentation of Osmetech's new OPTI device

click on "interactive hand-on experience" at the bottom of the page

WOW! no wonder they are selling so well !!

super post by "brummel" off the iii board .. quote


"IMHO we only need one approval covering the full functionality of the device. 1 x 6 months = 6 months with the four uses for the device being approved concurrently. UTI and BV are already approved anyway and OMH's previous statement says

"This sensor is now being incorporated into a new integrated point of care device for diagnosing and differentiating between the most prevalent and clinically important vaginal infections, including chlamydia and gonorrhea."

Note "including". Who says it's only four.

And if the UTI device can be upgraded later by adding new sensors (OMH's stated strategy)it may now suddenly be a lot more attractive if clinical trials on the combined device have proved that it works. Maybe there are buyers and/or a marketing partner in China or maybe there always was a marketing deal on the cards conditional on the combined device getting through clinical trials. Was there more to Roche's interest than the sale of OPTI. They have retained marketing rights over the new OPTI poc device, isn't it likely that they were also interested in the e-nose?

There is still more to know about the move to the US. Is the rationale to get the e-nose technologists in the same place as a new production line?

All the talk of acquisition encourages me. Is OMH planning to spend its up front money for the e-nose on this? It sounds as though the approval and marketing issues are far enough down the road to allow them to start broadening their horizons.

All conjecture before the results, but it all fits. The chances always were that when it all came together it would do so with a bang and IMHO events suggest that is near."

RJQ off the iii board .. quote


"Got the afternoon off work, phoned OMH and was lucky enough to get someone (male) to talk for a few moments, didn't give a name.

Osmetech are testing for the four most common std's, with BV makes five. There will indeed be only one more submission needed. It will be used as an early screen on both symptomatics and asymptomatics. There is no synergy with OPTI. OPTI gives Osmo worldwide access for the nose, I didn't get any particular response about China. There is the possibility that Osmo could manufacture themselves.

That's about all I needed to confirm.

Regards Roger"

10.3% rise in amorning is quite significant, no? Any news as to why this may have occured today?

Osmetech PLC. Evolution Beeson Gregory forecasts year to April pretax
profit 3.2 mln stg vs 4.7 mln.

Results due Wed.

Thanks prodman. Did a trawl on news but it seems like I'm missing the obvious!

prodman

Where are those figures from?? OMH have only had losses up to yet and were not expecting to go into profit, if it does it will only be small. The results are not due Wed but a week on Wed the 30th July

loafy:
Correct about the date, I copied the revelant parts from AFX news items.

12:31 pm 18/07/2003
OUTLOOK - UK COMPANY RESULTS FOR 2 WEEKS TO AUG 1

OUT ERN/GBR/
LONDON (AFX) - The following is a compilation of UK company results due out
in the 2 weeks to Aug 1


Osmetech PLC. Evolution Beeson Gregory forecasts year to April pretax profit
3.2 mln stg vs 4.7 mln.
newsdesk@afxnews.com

vjt/
For more information and to contact AFX: www.afxnews.com and www.afxpress.com


1231 18 Jul 03
3:24 pm 18/07/2003
LONDON SHARES - FEATURE MOVEMENTS AT 3.00 PM

Other risers
Osmetech 4.30 up 0.68 Results due Wednesday July 30
bge/leb/jmh/kl
For more information and to contact AFX: www.afxnews.com and www.afxpress.com
1524 18 Jul 03
Have a good weekend.
Prod.

great post by "Bucketfull" .. quote


"Bucketfull - 19 Jul'03 - 13:17 - 14253 of 14258


Whatever the short-term fluctuations in the share price, I think it will become glaringly obvious from the results that OMH are firmly ontrack to begin delivering on their goals in the very near term. Opti (for whatever reason) was clearly a very astute deal that has produced (and is likely to continue to produce) strong revenue - China's orders to date are known to some extent, but I am convinced that other territories will have been ordering above average too. Yesterday, I spotted a new distributor in Europe - how much other new interest has been generated due to the SARS news exposure? Those that claim SARS is 'finished' are completely missing the point.

Analysts/brokers will be revising their revenue estimates upwards, and (due to their USA relocation and the OPTI/POC synergy) the cashburn downwards. Therefore I conclude that OMH may be profitable significantly earlier than already anticipated. Furthermore, there may be news regarding a deal on the UTI device (EBG previously reported that talks were already underway in March). For these reasons alone I think a rapid increase in the share price is on the cards (10p-20p). Of course there will be pullbacks, spikes, shakeouts and all the rest, but this does not change the overall picture.

However, I also believe that the multiple device may be a lot further down the line than many seem to appreciate and if this does indeed become the 'gold-standard' (as independent commentators have said) then the share price should be a very large multiple of that at present. The earlier successful FDA approvals will surely assist in smoothing and accelerating the passage of the remaining (and future) submissions. With so much now coming ever closer to fruition, the newsflow and speculation is likely to be very strong over the next couple of years. Additionally there are the prospects of refinements and developments to the exisitng product range and the potential acquisition of other related products, like Opti.

Those only in for a quick 100-200% profit may be setting their sights very, very short, IMHO. OMH is currently priced at little over 4p after three years of savage bear-market. The FED have just raised their predictions for growth in the remaining quarters of this year and for 2004 - if we are to return to a full-on bull market, this can only enhance the liklihood of a far stronger share price. Pounds, not pence, is my goal."

and this is the distributor that Bucketfull mentions



http://www.lucronbioproducts.com/Vl/Menu.htm'

Post on @mple by BRUMMELL, well worth reading:

"I think that your comments reflect well the range of risk that different investors are prepared to bear. Some investors will be prepared to take a high level of risk in return for potentially high returns. Others will be more risk averse and will look at the current value of the company in relation to the shareprice and will not factor in much future potential until it happens. I think that you are right and that the current price is probably well supported by the OPTI fundamentals. That leaves us to assess the chances of OMH penetrating a market worth at least US$1.4bn to US$1.9bn PER ANNUM (see page 9 of offer/placing prospectus). The potential rewards of this venture are enormous. The path has not been smooth up to now and will doubtless have its problems in future but, IMHO, we are significantly closer to those rewards than we have ever been in the past.

To demonstrate why so many investors are prepared to take a risk with OMH lets do a few sums on the back of an envelope. The figures are so big that we don't need to be too precise and we can afford to underestimate for prudence. Even if OMH were to capture only 10% of the $1.4-$1.9bn market that would mean revenues of say $140m pa. A modest p/e ratio of say 15 would give us a market cap of over $2.1bn. The current market cap is about $33m so even on those modest figures we would be looking at a share price of say 2.80. The capitalisation figures are by no means outlandish in terms of US biotech growth (eg Amgen now at 59bn). The calculations are outrageously modest. Such is the nature of the product that the market penetration is likely to be much higher than 10%. The projected figures make no allowance for other applications that we know are in the pipeline and make no allowance for the highter rate of growth that would come from the vastly increased return on capital. Any negative aspects such as the need to raise more funds fade into insignificance, especially if done by way of debt. IMHO the management of OMH is second to none; it is mature in judgement, shrewd, financially prudent, willing to take risks and opportunistic. With every day that passes we get closer to the combined device coming to market. IMHO the risk today is lower than it has ever been in the past yet the price is near its lows, despite the fact it is underpinned by the OPTI fundamentals. At the current price you are getting all of the potential virtually for free.

IMHO again, next week's results will be a blockbuster because they will make all of the above clear to the market at large. They will also establish the management's credentials by showing what they have done with a $2.5m investment in just four short months. There may well also be other high quality good news on developments.

I hope, JJW, that the above goes some way to explaining why there is a hard core of investors in OMH who are prepared to back their own judgement that the risk is far less than the market currently rates it.

Let's hoep so, but without taking it personally where is the evidence that the management is up to the job? Not much so far on their traditional product....Their sensor has been about for many years and still nothing! They have shafted their loyal staff in Crewe and their loyal shareholders ( who put good money into PEP/ISA's only to have it destroyed before and as they moved to AIM ). One suspects the reason to change to AIM was the proposed move to the US, only a hunch you understand and time always tells the truth. Does a Full-listing mean you have to be resident here, in the UK?

Maybe they will get 10% of the market, but that is a huge rise in their circumstances and frankly, I don't believe it. They aren't known there, they have few contacts and they are a bunch of immigrants. I think it will take some time for them to get used to the culture, the cut and thrust, but heck - I'm always wrong, goodbuddy!

OMH is moving again folks - some good news in the pipeline (so the rumours have it). This could be a 5 to 10 bagger over the next 2 years - worth a closer look.

OMH has fallen away since August as is usual with small companies not in the news.

It is now heading for a support level just below 3p. At that level it will again present a buying opportunity IMO.

The OPTI bllod gas analyser seems to be a very useful device but news of sales is not available.

No news updates ar expected in the near future.

With OMH located in the US, a Nasdaq listing seems probable at some time IMO.

Fly by Night

Red

Any comments on why the sharp rise today? And what will happen in this week?

OMH have just sold 66 and a half million shares to institutions at the healthy price of 3p per share.

This increases the amount of instutional backing and hence reduces the risk for the rest of us.

The 2M will be used as follows:

James White, Chief Executive of Osmetech said,

"These funds raised will enable Osmetech to push ahead with its well-defined
product development programmes for the OPTI business, which has been
satisfactorily integrated into the Group and continues to perform ahead of
expectations. We plan to introduce new products over the next 9-18 months that
should enable this business to grow substantially.

"This additional cash will also strengthen our negotiating position with
potential partners and with respect to future M&A activity.

OMH is pushing gradually into a different league - they could attract a lot more interest for the rest of this week.

there has been alot of activity in these shares over the last few days ..shares have been heading in the upward direction .. does anyone hve any ideas or reasons for this ..

i hold these ..but am not aware of anything impending

maybe ugly duckling turn into a swan?? what can i say ,this is MY FATE!! :-((
9 month ago,i sensed maybe something would happened to the company that i gambled 90% of my trading fund into it hopping to get my trading account alive
again,(assumed 5 bagger in a year time),hence i lost the summer`s market rally!!! recently i dumped most of it , a mere 10%+ gains?

Suspected SAR`s case reoccuring in China,any link for OMH price raised today?

Latest Buyer vs Seller=9:1 on 3m+ shares traded. #10.10am.#

It appears to be the rush before the inevitable price hikes in the New Year bull run in preparation for the interims.

The interims will include 6 months OPTI sales (one month brought in US$1m and that was before SARs and China).

Watch macd & Roc, there seems have some positive signals appear, DYOR.

WATCH the trading Volume!! seems someone want to do something to curb the Price raising ups. :-)

already take off! one of my candidate for 2004 stock-picker competition.

OMH ,Oh! why few people bother to have a look at it? Few years back,this stock
priced at 30ish just based on some maybe big time hit concept onto the medicial
world,now the company begins to deliver some real stuff,and the price starts
moving ups.but how high it can goes this time then? DYOR.

Have you guys heard the latest rumours? - all over Dublin apparently. 10p bid rejected and 15p unconditional is one of the more detailed variants.

what?....i don't understand what is this rumours all about. overgrowth

All seem to be talking about this on advfn bb.personally dont belive it but if true great.

hello...leedslad.
advfn bb? i didn't get you. since i am new to this terminology...pls can you explain me a bit clear.

StockDreamer... there is another site for FREE live share prices and BB (buletin boards) at www.advfn.com A lot of the posters here also use ADVFN.
Hope this helps?

cheers Pal

thanx....pal

Osmetech PLC
13 January 2004

Osmetech plc ('Osmetech')

Notification of Interim Results announcement

Osmetech, the developer of medical devices, is to announce its interim results
for the six months to 31st October 2003, on Thursday 29th January 2004.

Ends


This information is provided by RNS
The company news service from the London Stock Exchange

nice little rise again ... expect it continue northwards leading upto results and after as analysts predict the results vll be good .. i hold some .

OG.,
re- your no 31 post,please don`t ramp the stock,let price takes its own course! i am still only halfway to my " 1m shares" target. I don`t want paying
too much to accum. it!! 10-15p? its a joke. I am looking for @100p+ after 3-5 years!OF course AS an INVESTOR. rgds, SBR

SBR,

No ramp intended, just curious to see if there was any substance to the rumours though it appears as though it was just hot air.

I'm only in for 100K at present, though if they keep nudging up, I could be tempted to build a stake and turn investor.

Cheers

OG

where are those rampers......

There's normally plenty to be found on advfn!

i have heard the same.

OG, price of the com. shown gradually raise on a market-down day,just a little bit disappointed that volume is`nt match it. Will add more while price break
last summer`s high. rgds SBR.

SBR, most of my small caps. tend to rise on a market down day. I've been eyeing up OMH for a possible T-trade also, though I've not been convinced that the short-term rise would warrant it.

This could be good news for long-termers, if all T-traders are thinking like me then there won't be the same fall in price after the results - this should help to drive the price past last summer's high. I've got a feeling that the results are going to be good (OPTI is the key), we should see further rises from tomorrow onwards - all will be revealed soon.

OG

guys, actions accelerate now,SIT TIGHT!

Excuse my ignorance. What is a T-trade?

Marty Boy,

It's the an extended settlement time some brokers allow.

It's possible to trade at e.g. T+15 which means that you order a chunk of shares today but don't have to pay for them until 15 days later.

You'll be charged a bit more than the normal broker's commission for the privilege, however it makes it possible to order a load of shares before results are due (hoping that the price will be rising in anticipation) and then sell just before results thereby making a profit on shares you never paid for in the first place!

OG

OMH closed near top today, if it break 5p & close above that level,it has some good story to tell, next price level? may hit 7p very soon, DYOR!

og,
Re-Omh,if at 7-13 pence range ,is in the final stage of its recovery,i think once the share price break pass this level,say 13.25p ,that is suggustion of a new milestone--begins of the growth phase story.To me it can be a multi baggers then. rgds SBR.

what a battle! If bull won at today`s closing session, the price should rocket tomorrow, if not?! JUST WAIT..... :-))

what is cx and what does it mean for the company ?

windy,

Check out:

http://futures.tradingcharts.com/learning/technical_indicators.html

SBR - I'm waiting :-))

I`m a bit surprise that the bear groups were SO strong in today`s battle!WHY bulls gave up ground so easily? If bulls do not reclaim some lost ground tomorrow, i`m afraid i`m wrong again !! (IT happened once approx 10 months ago.)

If results are supposed to be good this week, why did OMH drop 2 days before the
results are due.

Regards

MB

MB.,
OMH price did not drop compare to two days ago,what i`m not expect is : Bull
had`nt gain much ground since. rgds SBR.

Another negative day today. What is the prediction for results day tomorrow.

Regards

MB

Thanks for that og very informative site starting to understand things a little better now cheers windy

Results looking very healthy guys and plenty of buying going on today.

I'm surprised like SBR with the sells pre-results. This must have been short termers expecting a phenomenal short term profit like last time, selling out early due to uncertainty.

The good thing with this is that there should be few sells today which will should move the price into a new trading range.

og., refer to the company`s interim statement,i`m not convienced.what they `ve said we already knew! As an investor,i still kept 250k shares,will accum. more if they sign/bring in new contracts, as a trader, i`m out with a nice 40+% gains within 2 months. Best wish for you all. rgds SBR.

SBR, nice gain on the trading. From an investment point of view I think we are witnessing the start of OMH going places and with the new contracts which will come, 10p will be just around the corner.

OG

Og,agree about your point of view.This day, i try/learn to be a trading-investor rather than the oldday`s Buy& Hold investor! SBR.

I see there there approx 25m shares traded today how can you tell what was bought & what was sold.

Regards

MB

MB,

Click on the trades tab at the top of this page and type in the EPIC code for Osmetech i.e. OMH, you'll see a list of all the trades today.

There are always some unknown ones, if these are large and attract your interest you can see when they hit the market and look at the subsequent effect on the mid. price to work out if they were buys or sells. Some unknown trades are transfers between brokers and other deals which have no apparent effect on the trade price.

It was a close run match today with the buyers just in front of the sellers. I reckon most of the sellers (normally short term traders) will have got out today, so we should see a healthier rise tomorrow.

In the past OMH has normally been hyped up like crazy by short termers before results, who all sell immediately after the announcement or just before hammering the price right down. This announcement is different - the price actually went up - this means that the results were very good and show excellent potential for the future.

OG

Thanks OG for that. It was interesting. One thing that slightly concerns me is that the statement says that the second half of the year will be worse than the first half.
What are your views?
Where do you see the price in the next 6 months

Thanks

MB

MB,

The statement actually says:

"During the first half of the year, OPTI sales exceeded expectations at $5,582,000 (3,457,000), benefiting from approximately $1m of SARS-related sales to China early in the period and initial 'pipeline filling' sales to distributors. Although sales in the second half are not expected to continue to benefit from these factors, the underlying sales level for the full year should exceed expectations."

If the yearly sales are still going to exceed expectations then that is exactly what the market wants to hear. OMH have highlighted the reasons for the massive increase in sales in the first half and are very bullish about the full year figures. And what happens when the pipelines start to empty at all those new distributors? More sales.

I can see the price nudging up to around 7p in 6 months on the back of a bit more news/trading update/rumour etc. With news of new lucrative contracts this is likely to cause the price to soar to the dizzy heights of 10p and beyond.

OMH has always been that sort of share which could explode into blue territory any time. Lots of holders are waiting for exactly that time to happen before they even consider selling.

OG

MB,
what you got from the trade page refer to buy/sell volume is not a true picture at all!! If you want to see the true one ,you `ve to get a Level 2 quote. Other way to get around it,you can do your own homework:Construct an
OBV line yourself.A book call "the secret of selecting stocks for immediate & substantial gains"by Larry Williams may tell you some ideas you want /like to know. rgds SBR.

An interesting post from elsewhere today:

witten - 4 Feb'04 - 12:56


I have just now had a conversation with David Sandilands which I have found to be most encouraging. I asked about the UTI and he said that at the moment it was not at the forefront of their immediate plans. UTI would need further investment which OMH were not prepared to get involved in at the present time whilst there were and are far better and immediate commercial products to bring to the market during the next 6-18 months. OMH have done extremely well from the OPTI and intend to develop and market other products. The EVO estimates were based on the interims and they were not privy to any other information which could have led to their conclusions. Therefore any future deals would be in addition to these estimates. DS said that he would be most surprised if they did not do 15m per annum in 1-2 years time. They would always try to inform the market as to what was going on but obviously could not and would not inform the market in areas where the information was too sensitive in respect of their competition.
IMHO there is an extremely rosy period ahead. OMH are making decisions based on commercial feasibility and this I applaud wholeheartedly.


With thanks to 'witten'

Osmetech PLC
05 February 2004


Osmetech plc ('the Company')

Directors' Interests

The Company was informed on 4 February 2004 that on 4 February 2004, Mr James
White, a director of the Company, had purchased 220,000 ordinary shares of 1p
each ('Ordinary Shares') representing 0.04 per cent. of the issued share capital
of the Company at a price of 4.5p per share and that Mr. Gordon Hall, the
non-executive Chairman had purchased 110,000 Ordinary shares representing 0.02
per cent. of the issued share capital of the Company at a price of 4.5p per
share on the same date. Following this transaction Mr. White has an interest in
1,509,500 Ordinary Shares representing 0.26 per cent. of the issued share
capital of the Company and Mr. Hall has an interest in 763,946 Ordinary Shares
representing 0.13 per cent. of the issued share capital of the Company.




This information is provided by RNS
The company news service from the London Stock Exchange

Will Mr Sandilands be the next one to buy after his bullish statement? If so, then OMH is starting to look like a company due for spectacular growth over the next couple of years.

Still chance to buy into this company at less than 5p, if it is good enough for the directors to buy at 4.5p it is good enough for me. I have bought this morning and am expecting a reasonable profit over the next few months.

From the "Investor's Cronicle"


OSMETECH - GOOD VALUE

Osmetech has been transformed by last April's $2.75m acquisition of Roche's OPTI blood-gas analysers. OPTI has fortified the business with a revenue stream, a decent product pipeline and a quality distribution network. Blood-gas analysers test the levels of oxygen and carbon dioxide in the blood, as well as the pH or acidity, to determine the effectiveness of the respiratory system. Due to the SARS outbreak, OPTI made $1m of sales to China, meaning total revenues of $5.58m far exceeded expectations. The extra business has allowed it to plough more cash into research and development. In all, five new product launches are expected in 2004, including a reusable device with 50 tests on one cartridge.
Osmetech is now targeting larger hospitals because they conduct more tests and use more high margin consumables. It will use OPTI's presence in the GP market as a launch platform for it's own device, an all in one test for the five most common vaginal infections. Brokers expect a pre-tax loss of 1.8m for the full year.


I/C VIEW - With OPTI on board, Osmetech could be a profitable business right now. Instead it has chosen to invest in it's future, ploughing the profits back into snazzy new products that will help boost it's 14% share of the near-patient market blood gas analysers. Come 2006 that strategy should pay off. GOOD VALUE.

only dirs keep on buying and share price stays above a 5.5p base justify the story-changed call,then the company will growths bigger,or swallowed up by a bigger fish! I `m a long term fan of this com., and i also like to trade the stock.,DYOR!DYOR! If my anticipation is correct,next level price range starts from 5-13p and soon be arrived. SBR.

sbr,

Volume still looks healthy and the post-results dip has quickly been wiped out, this suggests there is a good level of confidence in the company with lots of new buyers coming in. Looks like a steady rise to just under 5p, then a small dip and then a sustained push upwards into 8p territory. We'll soon be looking at "20p next?" messages on the BB's.

Quote from "prof" on iii:

"This share is ready to take off...all the signs are there....strong cash position, revenue on stream, PR campaign underway, future products due to be launched and the VIP5 waiting around the corner." - Exactly my sentiments as a long term investor.

Still plenty of short term trading opportunities also - best of luck.

OG

og,
I did an OBV on this stock just from Dec/03 till now,volume ok,in positive territory,accum. pattern in place,if price break 26/1/04 high & volume match or surpass its previous level,it is a very rosy picture then. As i mention before,when the firm establish its growth phase,we are in a big winner!
rgds SBR.

"Shares" mag write up 5 Feb


OSMETECH (OMH) - 4.8P

The e-nose developer has transformed itself from a R&D based biotech to a company with revenues, thanks to it's acquistion of OPTI last year. Losses were slashed to 584,000 from 2 million last year. The company also racked up sales of 3.4 million, thanks to OPTI product sales, particulary boosted by a $1 million SARS-related order delivered to China of it's blood gas analyser instruments. Although these sales are unlikely to be replicated this year, Osmetech told Shares the rise of respiratory diseasa in Asia is likely to support further sales growth. Costs will be higher in the second half due to product launch costs. (PT)


Shares says:

Osmetech has turned the itself around - product launches may boost shares.

OG, What & where can the BB's be found. Also what is prof on iii?

SBR, What is an OBV?

Regards

MB

This is the link to the discussion!
http://www.iii.co.uk/investment/detail?display=discussion&code=cotn:OMH.L&it=le

Free registration required!

Fly by Night

Red

MB,
OBV is "on balance volume",just an indicator which try to tell who is the BOSS at the time being.Generally speaking ,not much useful for analyst a small/tiny firm like OMH.Because JUST a big buy/Sell order can change the whole picture completely! But until that happen,you may guess who is the dominant group. rgds SBR.

from the iii board by "Professor Higgins"


"Brummell

Thanks for the analysis much appreciated....my research and analysis also arrives at the 10p plus area...it is the timing of the arrival in this area that I am now constructing...using set release dates of finals and suggested timings of release of new products....all a little subjective but I have been right in the past..thats why i invested further funds on the 29th dec before the rush with a target of 4.5p.

The wild card is news of further contracts eg Thailand etc and when I mean new contracts I mean new sales rather than reagents doubles up profit as reagents will ne needed further down the line.

My assumption is that there will be at least one 'wild card' piece of news before finals...this will help accelerate the price past 5p and settle arround the 6/7p range....The FDA submission is due within the next month or so from my research and again this will add momentum....The finals will show improved sales but more reinvestment into the up and coming product line ...the lead up to the finals will see the share price move to a solid base of 10p etc...so summer will see a radically different share price with still considerable news to come in the latter half.....now this is where it gets interesting...

on the basis of the dates suggested by the interims product launches will occur in the last quarter...it would be prudent to assume that initial contracts will be achieved on or near product launch due to premarketing, OMH exposure through SARs and Bird virus related news...this will propel the share price into new waters...the difficult part as I have already said in previous comments is difficult to predict...and i will work this into my projections after finals are released...gut feel will be a similar rise seen by other certain companies who have moved from development to product launch....200/300% moves are not unknown...and this would derive a share price around 30p to 40p...well lets see.

Caution - There will be plenty of healthy pull backs and these should be seen as buying opportunities once the pattern is established (we are seeing it now with the share price trading well within the bid and offer prices and then the MMs reduce the offer to make it look like it is falling...however the price is consolidating around 4.5p...all that is happening is that some investors are being tempted to pay a higher price thinking good value but then see the offer price fall backn - any offer price below 4.5p would be a good price to buy for a medium/long term holder)

variables

New contracts for SARS and Bird Flu
New contracts for new product launches
Timing of FDA submission and sanction
Further progress with VIP5 to Asian countries and progress through any European body (version of USA FDA)
Any takeover activity (very doubtful at this time)

Anyway just a few thoughts. DYOR and be patient.

The Prof"

Can anyone explain all the activity on this one today?

Thanks,

Madison

OMH`s price supose to move from end/march-begin/april for its mini cycle,seems happen early this time!? But i won`t joint the party yet,patient is the name of the game. :))

does anyone know when osmetech q1 starts